Rigel Pharmaceuticals, Inc.
RIGL
$32.13
$2.769.40%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 146.68M | 154.96M | 137.14M | 108.38M | 77.10M |
| Total Receivables | 49.95M | 51.76M | 45.93M | 39.91M | 41.55M |
| Inventory | 25.06M | 23.36M | 20.61M | 15.83M | 16.39M |
| Prepaid Expenses | 5.20M | 4.89M | 5.39M | 5.84M | 5.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.14M | 5.21M | 5.86M | 5.44M | 6.38M |
| Total Current Assets | 234.03M | 240.17M | 214.93M | 175.39M | 146.56M |
|
|
|||||
| Total Current Assets | 234.03M | 240.17M | 214.93M | 175.39M | 146.56M |
| Net Property, Plant & Equipment | 785.00K | 950.00K | 1.10M | 1.24M | 1.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 24.16M | 24.75M | 25.34M | 25.92M | 26.51M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 245.64M | 247.73M | 1.17M | 4.18M | 1.52M |
| Total Assets | 504.61M | 513.59M | 242.53M | 206.74M | 175.97M |
|
|
|||||
| Total Accounts Payable | 4.49M | 7.19M | 3.85M | 7.29M | 3.95M |
| Total Accrued Expenses | 44.43M | 50.46M | 48.98M | 45.18M | 41.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 30.50M | 30.43M | 30.36M | 22.88M | 15.27M |
| Total Finance Division Other Current Liabilities | 10.08M | 11.16M | 11.22M | 11.28M | 5.85M |
| Total Other Current Liabilities | 10.08M | 11.16M | 11.22M | 11.28M | 5.85M |
| Total Current Liabilities | 89.49M | 99.24M | 94.40M | 86.64M | 66.63M |
|
|
|||||
| Total Current Liabilities | 89.49M | 99.24M | 94.40M | 86.64M | 66.63M |
| Long-Term Debt | 14.99M | 22.48M | 29.97M | 37.45M | 84.91M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 228.00K | 395.00K | 556.00K | 714.00K | 864.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 5.00M |
| Total Liabilities | 104.71M | 122.11M | 124.93M | 124.80M | 157.41M |
|
|
|||||
| Common Stock & APIC | 1.41B | 1.41B | 1.41B | 1.40B | 1.40B |
| Retained Earnings | -1.01B | -1.02B | -1.29B | -1.32B | -1.38B |
| Treasury Stock & Other | -128.00K | 181.00K | 96.00K | 6.00K | -2.00K |
| Total Common Equity | 399.90M | 391.48M | 117.61M | 81.93M | 18.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 399.90M | 391.48M | 117.61M | 81.93M | 18.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 399.90M | 391.48M | 117.61M | 81.93M | 18.57M |
|
|
|||||